The gut microbiome is a complex and dynamic community of commensal, symbiotic, and pathogenic microorganisms that exist in a bidirectional relationship with the host. Bacterial functions in the gut play a critical role in healthy host functioning, and its disruption can contribute to many medical conditions. The relationship between gut microbiota and the brain has gained attention in mental health due to the mounting evidence supporting the association of gut bacteria with mood and behavior. Patients with bipolar disorder exhibit an increased frequency of gastrointestinal illnesses such as inflammatory bowel disease, which mechanistically has been linked to microbial community function. While the heterogeneity in microbial communities between individuals might be associated with disease risk, it may also moderate the efficacy or adverse effects associated with the use of medication. The following review highlights published evidence linking the function of gut microbiota both to bipolar disorder risk and to the effect of medications that influence microbiota, inflammation, and mood symptoms.

1.
Grande
I
,
Berk
M
,
Birmaher
B
,
Vieta
E
.
Bipolar disorder
.
Lancet
.
2016
Apr
;
387
(
10027
):
1561
72
.
[PubMed]
0140-6736
2.
Alonso
J
,
Petukhova
M
,
Vilagut
G
,
Chatterji
S
,
Heeringa
S
,
Üstün
TB
, et al.
Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys
.
Mol Psychiatry
.
2011
Dec
;
16
(
12
):
1234
46
.
[PubMed]
1359-4184
3.
Whiteford
HA
,
Degenhardt
L
,
Rehm
J
,
Baxter
AJ
,
Ferrari
AJ
,
Erskine
HE
, et al.
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
.
Lancet
.
2013
Nov
;
382
(
9904
):
1575
86
.
[PubMed]
0140-6736
4.
Post
RM
.
The impact of bipolar depression
.
J Clin Psychiatry
.
2005
;
66
Suppl 5
:
5
10
.
[PubMed]
0160-6689
5.
Purcell
SM
,
Wray
NR
,
Stone
JL
,
Visscher
PM
,
O’Donovan
MC
,
Sullivan
PF
, et al.;
International Schizophrenia Consortium
.
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
.
Nature
.
2009
Aug
;
460
(
7256
):
748
52
.
[PubMed]
0028-0836
6.
Lichtenstein
P
,
Yip
BH
,
Björk
C
,
Pawitan
Y
,
Cannon
TD
,
Sullivan
PF
, et al.
Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study
.
Lancet
.
2009
Jan
;
373
(
9659
):
234
9
.
[PubMed]
0140-6736
7.
Van Snellenberg
JX
,
de Candia
T
.
Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder
.
Arch Gen Psychiatry
.
2009
Jul
;
66
(
7
):
748
55
.
[PubMed]
0003-990X
8.
Clarke
G
,
Stilling
RM
,
Kennedy
PJ
,
Stanton
C
,
Cryan
JF
,
Dinan
TG
.
Minireview: Gut microbiota: the neglected endocrine organ
.
Mol Endocrinol
.
2014
Aug
;
28
(
8
):
1221
38
.
[PubMed]
0888-8809
9.
McCarthy
JJ
,
McLeod
HL
,
Ginsburg
GS
.
Genomic medicine: a decade of successes, challenges, and opportunities
.
Sci Transl Med
.
2013
Jun
;
5
(
189
):
189sr4
.
[PubMed]
1946-6234
10.
ElRakaiby
M
,
Dutilh
BE
,
Rizkallah
MR
,
Boleij
A
,
Cole
JN
,
Aziz
RK
.
Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics
.
OMICS
.
2014
Jul
;
18
(
7
):
402
14
.
[PubMed]
1536-2310
11.
Lovell
RM
,
Ford
AC
.
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis
.
Clin Gastroenterol Hepatol
.
2012
Jul
;
10
(
7
):
712
721.e4
.
[PubMed]
1542-3565
12.
Whitehead
WE
,
Palsson
O
,
Jones
KR
.
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?
Gastroenterology
.
2002
Apr
;
122
(
4
):
1140
56
.
[PubMed]
0016-5085
13.
Roy-Byrne
PP
,
Davidson
KW
,
Kessler
RC
,
Asmundson
GJ
,
Goodwin
RD
,
Kubzansky
L
, et al.
Anxiety disorders and comorbid medical illness
.
Gen Hosp Psychiatry
.
2008
May-Jun
;
30
(
3
):
208
25
.
[PubMed]
0163-8343
14.
Tseng
PT
,
Zeng
BS
,
Chen
YW
,
Wu
MK
,
Wu
CK
,
Lin
PY
.
A meta-analysis and systematic review of the comorbidity between irritable bowel syndrome and bipolar disorder
.
Medicine (Baltimore)
.
2016
Aug
;
95
(
33
):
e4617
.
[PubMed]
0025-7974
15.
Piché
M
,
Chen
JI
,
Roy
M
,
Poitras
P
,
Bouin
M
,
Rainville
P
.
Thicker posterior insula is associated with disease duration in women with irritable bowel syndrome (IBS) whereas thicker orbitofrontal cortex predicts reduced pain inhibition in both IBS patients and controls
.
J Pain
.
2013
Oct
;
14
(
10
):
1217
26
.
[PubMed]
1526-5900
16.
Ellingson
BM
,
Mayer
E
,
Harris
RJ
,
Ashe-McNally
C
,
Naliboff
BD
,
Labus
JS
, et al.
Diffusion tensor imaging detects microstructural reorganization in the brain associated with chronic irritable bowel syndrome
.
Pain
.
2013
Sep
;
154
(
9
):
1528
41
.
[PubMed]
0304-3959
17.
Labus
JS
,
Hollister
EB
,
Jacobs
J
,
Kirbach
K
,
Oezguen
N
,
Gupta
A
, et al.
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome
.
Microbiome
.
2017
May
;
5
(
1
):
49
.
[PubMed]
2049-2618
18.
Houser
MC
,
Tansey
MG
.
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
NPJ Parkinsons Dis
.
2017
Jan
;
3
(
1
):
3
.
[PubMed]
2373-8057
19.
Jobin
C
,
Sartor
RB
.
The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection
.
Am J Physiol Cell Physiol
.
2000
Mar
;
278
(
3
):
C451
62
.
[PubMed]
0363-6143
20.
Marcial
GE
,
Ford
AL
,
Haller
MJ
,
Gezan
SA
,
Harrison
NA
,
Cai
D
, et al.
Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults
.
Front Immunol
.
2017
Jun
;
8
:
655
.
[PubMed]
1664-3224
21.
Zhao
Y
,
Cong
L
,
Jaber
V
,
Lukiw
WJ
.
Microbiome-Derived Lipopolysaccharide Enriched in the Perinuclear Region of Alzheimer’s Disease Brain
.
Front Immunol
.
2017
Sep
;
8
:
1064
.
[PubMed]
1664-3224
22.
Abraham
C
,
Medzhitov
R
.
Interactions between the host innate immune system and microbes in inflammatory bowel disease
.
Gastroenterology
.
2011
May
;
140
(
6
):
1729
37
.
[PubMed]
0016-5085
23.
Schirmer
M
,
Smeekens
SP
,
Vlamakis
H
,
Jaeger
M
,
Oosting
M
,
Franzosa
EA
, et al.
Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity
.
Cell
.
2016
Nov
;
167
(
4
):
1125
1136.e8
.
[PubMed]
0092-8674
24.
Bai
YM
,
Su
TP
,
Tsai
SJ
,
Wen-Fei
C
,
Li
CT
,
Pei-Chi
T
, et al.
Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder
.
J Affect Disord
.
2014
Sep
;
166
:
187
92
.
[PubMed]
0165-0327
25.
Severance
EG
,
Alaedini
A
,
Yang
S
,
Halling
M
,
Gressitt
KL
,
Stallings
CR
, et al.
Gastrointestinal inflammation and associated immune activation in schizophrenia
.
Schizophr Res
.
2012
Jun
;
138
(
1
):
48
53
.
[PubMed]
0920-9964
26.
Severance
EG
,
Gressitt
KL
,
Stallings
CR
,
Katsafanas
E
,
Schweinfurth
LA
,
Savage
CL
, et al.
Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder
.
NPJ Schizophr
.
2016
May
;
2
(
1
):
16018
.
[PubMed]
2334-265X
27.
Severance
EG
,
Gressitt
KL
,
Stallings
CR
,
Origoni
AE
,
Khushalani
S
,
Leweke
FM
, et al.
Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia
.
Schizophr Res
.
2013
Aug
;
148
(
1-3
):
130
7
.
[PubMed]
0920-9964
28.
Kim
YK
,
Jung
HG
,
Myint
AM
,
Kim
H
,
Park
SH
.
Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
.
J Affect Disord
.
2007
Dec
;
104
(
1-3
):
91
5
.
[PubMed]
0165-0327
29.
Debnath
M
,
Berk
M
.
Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications
.
Schizophr Bull
.
2014
Nov
;
40
(
6
):
1412
21
.
[PubMed]
0586-7614
30.
Severance
EG
,
Gressitt
KL
,
Yang
S
,
Stallings
CR
,
Origoni
AE
,
Vaughan
C
, et al.
Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder
.
Bipolar Disord
.
2014
May
;
16
(
3
):
230
40
.
[PubMed]
1398-5647
31.
Dennison
U
,
McKernan
D
,
Cryan
J
,
Dinan
T
.
Schizophrenia patients with a history of childhood trauma have a pro-inflammatory phenotype
.
Psychol Med
.
2012
Sep
;
42
(
9
):
1865
71
.
[PubMed]
0033-2917
32.
Goldsmith
DR
,
Rapaport
MH
,
Miller
BJ
.
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
.
Mol Psychiatry
.
2016
Dec
;
21
(
12
):
1696
709
.
[PubMed]
1359-4184
33.
Meyer
U
,
Feldon
J
.
Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia
.
Psychopharmacology (Berl)
.
2009
Nov
;
206
(
4
):
587
602
.
[PubMed]
0033-3158
34.
Severance
EG
,
Gressitt
KL
,
Stallings
CR
,
Katsafanas
E
,
Schweinfurth
LA
,
Savage
CL
, et al.
Probiotic normalization of Candida albicans in schizophrenia: A randomized, placebo-controlled, longitudinal pilot study
.
Brain Behav Immun
.
2017
May
;
62
:
41
5
.
[PubMed]
0889-1591
35.
Anderson
G
,
Maes
M
.
Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites
.
Curr Psychiatry Rep
.
2015
Feb
;
17
(
2
):
8
.
[PubMed]
1523-3812
36.
Myint
AM
,
Kim
YK
,
Verkerk
R
,
Park
SH
,
Scharpé
S
,
Steinbusch
HW
, et al.
Tryptophan breakdown pathway in bipolar mania
.
J Affect Disord
.
2007
Sep
;
102
(
1-3
):
65
72
.
[PubMed]
0165-0327
37.
O’Mahony
SM
,
Clarke
G
,
Borre
YE
,
Dinan
TG
,
Cryan
JF
.
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
.
Behav Brain Res
.
2015
Jan
;
277
:
32
48
.
[PubMed]
0166-4328
38.
Anderson
G
,
Jacob
A
,
Bellivier
F
,
Geoffroy
PA
.
Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways
.
Curr Pharm Des
.
2016
;
22
(
8
):
987
1012
.
[PubMed]
1381-6128
39.
Larkin
PB
,
Sathyasaikumar
KV
,
Notarangelo
FM
,
Funakoshi
H
,
Nakamura
T
,
Schwarcz
R
, et al.
Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice
.
Biochim Biophys Acta
.
2016
Nov
;
1860
(
11
11 Pt A
):
2345
54
.
[PubMed]
0006-3002
40.
Mok
MH
,
Fricker
AC
,
Weil
A
,
Kew
JN
.
Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels
.
Neuropharmacology
.
2009
Sep
;
57
(
3
):
242
9
.
[PubMed]
0028-3908
41.
Lugo-Huitrón
R
,
Ugalde Muñiz
P
,
Pineda
B
,
Pedraza-Chaverrí
J
,
Ríos
C
,
Pérez-de la Cruz
V
. (
2013
) Quinolinic Acid: An Endogenous Neurotoxin with Multiple Targets. In: Oxidative Medicine and Cellular Longevity.
42.
Birner
A
,
Platzer
M
,
Bengesser
SA
,
Dalkner
N
,
Fellendorf
FT
,
Queissner
R
, et al.
Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder
.
PLoS One
.
2017
Feb
;
12
(
2
):
e0172699
.
[PubMed]
1932-6203
43.
Metz
R
,
Smith
C
,
DuHadaway
JB
,
Chandler
P
,
Baban
B
,
Merlo
LM
, et al.
IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation
.
Int Immunol
.
2014
Jul
;
26
(
7
):
357
67
.
[PubMed]
0953-8178
44.
Penberthy
WT
;
W. T. Penberthy
.
Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease
.
Curr Drug Metab
.
2007
Apr
;
8
(
3
):
245
66
.
[PubMed]
1389-2002
45.
Vujkovic-Cvijin
I
,
Swainson
LA
,
Chu
SN
,
Ortiz
AM
,
Santee
CA
,
Petriello
A
, et al.
Gut-Resident Lactobacillus Abundance Associates with IDO1 Inhibition and Th17 Dynamics in SIV-Infected Macaques
.
Cell Rep
.
2015
Nov
;
13
(
8
):
1589
97
.
[PubMed]
2639-1856
46.
Strasser
B
,
Geiger
D
,
Schauer
M
,
Gostner
JM
,
Gatterer
H
,
Burtscher
M
, et al.
Probiotic Supplements Beneficially Affect Tryptophan-Kynurenine Metabolism and Reduce the Incidence of Upper Respiratory Tract Infections in Trained Athletes: A Randomized, Double-Blinded, Placebo-Controlled Trial
.
Nutrients
.
2016
Nov
;
8
(
11
):
8
.
[PubMed]
2072-6643
47.
Johnson
KV
,
Foster
KR
.
Why does the microbiome affect behaviour?
Nat Rev Microbiol
.
2018
Oct
;
16
(
10
):
647
55
.
[PubMed]
1740-1526
48.
Stefano
GB
,
Pilonis
N
,
Ptacek
R
,
Raboch
J
,
Vnukova
M
,
Kream
RM
.
Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders
.
Cell Mol Neurobiol
.
2018
Aug
;
38
(
6
):
1197
206
.
[PubMed]
0272-4340
49.
Sudo
N
,
Chida
Y
,
Aiba
Y
,
Sonoda
J
,
Oyama
N
,
Yu
XN
, et al.
Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice
.
J Physiol
.
2004
Jul
;
558
(
Pt 1
):
263
75
.
[PubMed]
0022-3751
50.
Clarke
G
,
Grenham
S
,
Scully
P
,
Fitzgerald
P
,
Moloney
RD
,
Shanahan
F
, et al.
The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner
.
Mol Psychiatry
.
2013
Jun
;
18
(
6
):
666
73
.
[PubMed]
1359-4184
51.
Diaz Heijtz
R
,
Wang
S
,
Anuar
F
,
Qian
Y
,
Björkholm
B
,
Samuelsson
A
, et al.
Normal gut microbiota modulates brain development and behavior
.
Proc Natl Acad Sci USA
.
2011
Feb
;
108
(
7
):
3047
52
.
[PubMed]
0027-8424
52.
Neufeld
KM
,
Kang
N
,
Bienenstock
J
,
Foster
JA
(
2011
)
Reduced anxiety-like behavior and central neurochemical change in germ-free mice.
Neurogastroenterol Motil 23:255–264, e119 .
53.
Evans
SJ
,
Bassis
CM
,
Hein
R
,
Assari
S
,
Flowers
SA
,
Kelly
MB
, et al.
The gut microbiome composition associates with bipolar disorder and illness severity
.
J Psychiatr Res
.
2017
Apr
;
87
:
23
9
.
[PubMed]
0022-3956
54.
Sokol
H
,
Pigneur
B
,
Watterlot
L
,
Lakhdari
O
,
Bermúdez-Humarán
LG
,
Gratadoux
JJ
, et al.
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
.
Proc Natl Acad Sci USA
.
2008
Oct
;
105
(
43
):
16731
6
.
[PubMed]
0027-8424
55.
Sokol
H
,
Seksik
P
,
Furet
JP
,
Firmesse
O
,
Nion-Larmurier
I
,
Beaugerie
L
, et al.
Low counts of Faecalibacterium prausnitzii in colitis microbiota
.
Inflamm Bowel Dis
.
2009
Aug
;
15
(
8
):
1183
9
.
[PubMed]
1078-0998
56.
Wong
VW
,
Tse
CH
,
Lam
TT
,
Wong
GL
,
Chim
AM
,
Chu
WC
, et al.
Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis—a longitudinal study
.
PLoS One
.
2013
Apr
;
8
(
4
):
e62885
.
[PubMed]
1932-6203
57.
Aizawa
E
,
Tsuji
H
,
Asahara
T
,
Takahashi
T
,
Teraishi
T
,
Yoshida
S
, et al.
Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder
.
J Affect Disord
.
2016
Sep
;
202
:
254
7
.
[PubMed]
0165-0327
58.
Jiang
H
,
Ling
Z
,
Zhang
Y
,
Mao
H
,
Ma
Z
,
Yin
Y
, et al.
Altered fecal microbiota composition in patients with major depressive disorder
.
Brain Behav Immun
.
2015
Aug
;
48
:
186
94
.
[PubMed]
0889-1591
59.
Mason
B
,
Koh
A
,
Enkevort
EV
,
Trivedi
M
.
676. Gut Microbiota Distributions Predict Mood Disorder Symptoms and Mediate Dietary Interactions
.
Biol Psychiatry
.
2017
;
81
(
10
):
S273
4
. 0006-3223
60.
Painold
A
,
Mörkl
S
,
Kashofer
K
,
Halwachs
B
,
Dalkner
N
,
Bengesser
S
, et al.
A step ahead: exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode
.
Bipolar Disord
.
2019
Feb
;
21
(
1
):
40
9
.
[PubMed]
1398-5647
61.
Yatham
LN
,
Kennedy
SH
,
Parikh
SV
,
Schaffer
A
,
Bond
DJ
,
Frey
BN
, et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
.
Bipolar Disord
.
2018
Mar
;
20
(
2
):
97
170
.
[PubMed]
1398-5647
62.
Tohen
M
,
Zarate
CA
 Jr
,
Hennen
J
,
Khalsa
HM
,
Strakowski
SM
,
Gebre-Medhin
P
, et al.
The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence
.
Am J Psychiatry
.
2003
Dec
;
160
(
12
):
2099
107
.
[PubMed]
0002-953X
63.
Selwyn
FP
,
Cheng
SL
,
Klaassen
CD
,
Cui
JY
.
Regulation of Hepatic Drug-Metabolizing Enzymes in Germ-Free Mice by Conventionalization and Probiotics
.
Drug Metab Dispos
.
2016
Feb
;
44
(
2
):
262
74
.
[PubMed]
0090-9556
64.
Kuntz
TM
,
Gilbert
JA
.
Introducing the Microbiome into Precision Medicine
.
Trends Pharmacol Sci
.
2017
Jan
;
38
(
1
):
81
91
.
[PubMed]
0165-6147
65.
Maier
L
,
Pruteanu
M
,
Kuhn
M
,
Zeller
G
,
Telzerow
A
,
Anderson
EE
, et al.
Extensive impact of non-antibiotic drugs on human gut bacteria
.
Nature
.
2018
Mar
;
555
(
7698
):
623
8
.
[PubMed]
0028-0836
66.
Lähteenvuo
M
,
Tanskanen
A
,
Taipale
H
,
Hoti
F
,
Vattulainen
P
,
Vieta
E
, et al.
Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder
.
JAMA Psychiatry
.
2018
Apr
;
75
(
4
):
347
55
.
[PubMed]
2168-622X
67.
Cussotto
S
,
Strain
CR
,
Fouhy
F
,
Strain
RG
,
Peterson
VL
,
Clarke
G
, et al.
Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function
.
Psychopharmacology (Berl)
.
2019
May
;
236
(
5
):
1671
85
.
[PubMed]
0033-3158
68.
McEvoy
JP
,
Meyer
JM
,
Goff
DC
,
Nasrallah
HA
,
Davis
SM
,
Sullivan
L
, et al.
Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III
.
Schizophr Res
.
2005
Dec
;
80
(
1
):
19
32
.
[PubMed]
0920-9964
69.
Schneeberger
M
,
Everard
A
,
Gómez-Valadés
AG
,
Matamoros
S
,
Ramírez
S
,
Delzenne
NM
, et al.
Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice
.
Sci Rep
.
2015
Nov
;
5
(
1
):
16643
.
[PubMed]
2045-2322
70.
Morgan
AP
,
Crowley
JJ
,
Nonneman
RJ
,
Quackenbush
CR
,
Miller
CN
,
Ryan
AK
, et al.
The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse
.
PLoS One
.
2014
Dec
;
9
(
12
):
e115225
.
[PubMed]
1932-6203
71.
Davey
KJ
,
O’Mahony
SM
,
Schellekens
H
,
O’Sullivan
O
,
Bienenstock
J
,
Cotter
PD
, et al.
Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters
.
Psychopharmacology (Berl)
.
2012
May
;
221
(
1
):
155
69
.
[PubMed]
0033-3158
72.
Davey
KJ
,
Cotter
PD
,
O’Sullivan
O
,
Crispie
F
,
Dinan
TG
,
Cryan
JF
, et al.
Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat
.
Transl Psychiatry
.
2013
Oct
;
3
(
10
):
e309
.
[PubMed]
2158-3188
73.
Bahr
SM
,
Tyler
BC
,
Wooldridge
N
,
Butcher
BD
,
Burns
TL
,
Teesch
LM
, et al.
Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children
.
Transl Psychiatry
.
2015
Oct
;
5
(
10
):
e652
.
[PubMed]
2158-3188
74.
Flowers
SA
,
Evans
SJ
,
Ward
KM
,
McInnis
MG
,
Ellingrod
VL
.
Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort
.
Pharmacotherapy
.
2017
Mar
;
37
(
3
):
261
7
.
[PubMed]
0277-0008
75.
Flowers
SA
,
Baxter
NT
,
Ward
KM
,
Kraal
AZ
,
McInnis
MG
,
Schmidt
TM
, et al.
Effects of Atypical Antipsychotic Treatment and Resistant Starch Supplementation on Gut Microbiome Composition in a Cohort of Patients with Bipolar Disorder or Schizophrenia
.
Pharmacotherapy
.
2019
Feb
;
39
(
2
):
161
70
.
[PubMed]
0277-0008
76.
Cascade
EF
,
Reites
J
,
Kalali
AH
,
Ghaemi
N
.
Antidepressants in bipolar disorder
.
Psychiatry (Edgmont)
.
2007
Mar
;
4
(
3
):
56
8
.
[PubMed]
1555-5194
77.
Macedo
D
,
Filho
AJ
,
Soares de Sousa
CN
,
Quevedo
J
,
Barichello
T
,
Júnior
HV
, et al.
Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness
.
J Affect Disord
.
2017
Jan
;
208
:
22
32
.
[PubMed]
0165-0327
78.
Ayaz
M
,
Subhan
F
,
Ahmed
J
,
Khan
AU
,
Ullah
F
,
Ullah
I
, et al.
Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance
.
J Biol Res (Thessalon)
.
2015
Apr
;
22
(
1
):
4
.
[PubMed]
1790-045X
79.
Coban
AY
,
Tanriverdi Cayci
Y
,
Keleş Uludağ
S
,
Durupinar
B
.
[Investigation of antibacterial activity of sertralin]
.
Mikrobiyol Bul
.
2009
Oct
;
43
(
4
):
651
6
.
[PubMed]
0374-9096
80.
Kruszewska
H
,
Zareba
T
,
Tyski
S
.
Examination of antimicrobial activity of selected non-antibiotic medicinal preparations
.
Acta Pol Pharm
.
2012
Nov-Dec
;
69
(
6
):
1368
71
.
[PubMed]
0001-6837
81.
Rogers
MA
,
Greene
MT
,
Young
VB
,
Saint
S
,
Langa
KM
,
Kao
JY
, et al.
Depression, antidepressant medications, and risk of Clostridium difficile infection
.
BMC Med
.
2013
May
;
11
(
1
):
121
.
[PubMed]
1741-7015
82.
Liu
F
,
Horton-Sparks
K
,
Hull
V
,
Li
RW
,
Martínez-Cerdeño
V
.
The valproic acid rat model of autism presents with gut bacterial dysbiosis similar to that in human autism
.
Mol Autism
.
2018
Dec
;
9
(
1
):
61
.
[PubMed]
2040-2392
83.
Stokes
JM
,
Davis
JH
,
Mangat
CS
,
Williamson
JR
,
Brown
ED
.
Discovery of a small molecule that inhibits bacterial ribosome biogenesis
.
eLife
.
2014
Sep
;
3
:
e03574
.
[PubMed]
2050-084X
84.
Qian
Y
,
Lv
PC
,
Fang
RQ
,
Song
ZC
,
Zhu
HL
.
Synthesis, antimicrobial activity of lamotrigine and its ammonium derivatives
.
J Chem Sci
.
2009
;
121
(
4
):
463
70
. 0253-4134
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.